-+ 0.00%
-+ 0.00%
-+ 0.00%

Sinopharm FY26 1H net profit rises 2.95% to RMB 5.34 billion; revenue increases 1.13% to RMB 286.04 billion

PUBT·08/24/2026 01:05:21
Listen to the news
Sinopharm FY26 1H net profit rises 2.95% to RMB 5.34 billion; revenue increases 1.13% to RMB 286.04 billion
  • Sinopharm posted 2026 1H revenue of RMB 286.04 billion, up 1.13%, while net profit rose 2.95% to RMB 5.34 billion.
  • Net profit attributable to owners of the parent slipped 1.79% to RMB 3.4 billion; gross margin narrowed 0.37 percentage points to 6.74%.
  • Operating cash outflow narrowed to RMB 23.76 billion from RMB 34.11 billion; gearing ratio edged up 0.66 percentage points to 66.29%.
  • Pharmaceutical distribution revenue dipped 1.39% to RMB 215.5 billion, but operating profit climbed 7.75% to RMB 5.65 billion.
  • Retail pharmacy revenue increased 8.58% to RMB 18.64 billion; store count rose to 8,221 as of end-June from 7,975.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.